Credence Research Logo

Home » Marknaden för bioläkemedel

Marknaden för bioläkemedel efter produkttyp (monoklonala antikroppar, rekombinanta proteiner, rekombinanta hormoner, vacciner, rekombinanta enzymer, cell- och genterapier, cytokiner, interferoner och interleukiner, tillväxtfaktorer, andra produkttyper); efter terapeutisk tillämpning (onkologi, inflammatoriska och infektionssjukdomar, autoimmuna sjukdomar, metabola sjukdomar, hormonella sjukdomar, kardiovaskulära sjukdomar, neurologiska sjukdomar, andra terapeutiska tillämpningar); efter läkemedelstyp (patentskyddade/varumärkesskyddade biologiska läkemedel, biosimilarer); efter region – tillväxt, andel, möjligheter och konkurrensanalys, 2025 – 2032

Report ID: 206230 | Report Format : Excel, PDF

Begär ett gratisprov

Begär gratis prov

We prioritize the confidentiality and security of your data. Our promise: your information remains private.

Ready to Transform Data into Decisions?

Begär din provrapport och börja din resa mot välgrundade beslut

Tillhandahåller den strategiska kompassen för branschledare.

cr-clients-logos
Vanliga frågor:
Vad är marknadsstorleken för biopharmaceuticals-marknaden år 2025 och prognosen för 2032?

Biopharmaceuticals-marknaden värderades till 457 158,2 miljoner USD år 2025. Marknaden förväntas nå 783 488,82 miljoner USD år 2032.

Vad är CAGR för biopharmaceuticals-marknaden under 2025–2032?

Marknaden förväntas växa med en CAGR på 8% från 2025 till 2032. Denna tillväxt återspeglar en ökad adoption inom specialterapiområden och en utvidgning av tillgången.

Vilket är det största segmentet efter produkttyp år 2025?

Monoklonala antikroppar är den största produktsegmentet. Monoklonala antikroppar stod för 35,4% av marknadsandelen år 2025.

Vilka är de viktigaste faktorerna som driver biopharmaceuticals-marknaden?

Nyckelfaktorer för tillväxt inkluderar en ökande börda av specialiserade sjukdomar, fortsatt innovation inom biologiska plattformar och en expanderande tillverkningskapacitet. Förbättrad tillgång och överkomliga priser genom biosimilarer stöder också en bredare adoption.

Vilka är de ledande företagen på biopharmaceuticals-marknaden?

Ledande företag inkluderar Pfizer Inc., AbbVie Inc., Merck & Co., Inc., F. Hoffmann-La Roche Ltd. och Novartis AG. Andra stora aktörer inkluderar Johnson & Johnson Services, Inc., Bristol-Myers Squibb Company och Sanofi.

Vilken region leder biopharmaceuticalsmarknaden 2025?

Nordamerika leder marknaden 2025. Nordamerika stod för 43,6% av den globala intäkten 2025.

About Author

Shweta Bisht

Shweta Bisht

Healthcare & Biotech Analyst

Shweta is a healthcare and biotech researcher with strong analytical skills in chemical and agri domains.

View Profile

Related Reports

Oral Macromolecular Formulation Market

The Oral Macromolecular Formulation market size was valued at USD 9 million in 2024 and is projected to reach USD 12.51 million by 2032, reflecting a CAGR of 4.8% during the forecast period.

Ineffective Esophageal Motility Treatment Market

The Ineffective Esophageal Motility Treatment market size was valued at USD 4,680 million in 2024 and is projected to reach USD 7,402.47 million by 2032, growing at a CAGR of 5.9% during the forecast period.

At-Home Molecular Testing Market

At Home Molecular Testing market size was valued at USD 10,809 million in 2024 and is anticipated to reach USD 16,463.2 million by 2032, growing at a CAGR of 5.4% during the forecast period.

OTC Cough Cold And Allergy Medicine Market

The global OTC cough, cold, and allergy medicine market was valued at USD 23,450 million in 2024 and is projected to reach USD 32,590.02 million by 2032, expanding at a compound annual growth rate (CAGR) of 4.2% during the forecast period.

Novel Cardiovascular Drug Delivery Devices Market

Novel Cardiovascular Drug Delivery Devices Market size was valued USD 5189 million in 2024 and is anticipated to reach USD 9322.84 million by 2032, at a CAGR of 7.6% during the forecast period.

Small Molecule Injectable Market

The Small Molecule Injectable market was valued at USD 141,836 million in 2024 and is anticipated to reach USD 241,884.7 million by 2032, growing at a CAGR of 6.9% during the forecast period.

Nanoparticle Formulation Market

Nanoparticle Formulation Market size was valued USD 8589 million in 2024 and is anticipated to reach USD 16863.73 million by 2032, at a CAGR of 8.8% during the forecast period.

Autologous Conditioned Plasma (ACP) Market

Autologous Conditioned Plasma (ACP) Market size was valued USD 584 million in 2024 and is anticipated to reach USD 1366.31 million by 2032, at a CAGR of 11.2% during the forecast period.

Autogenous Vaccine Market

Autogenous Vaccine Market size was valued USD 465 million in 2024 and is anticipated to reach USD 810.46 million by 2032, at a CAGR of 7.2% during the forecast period.

Combination Therapies In Aesthetics Market

The global combination therapies in aesthetics market was valued at USD 3,690 million in 2024 and is projected to reach USD 6,880.69 million by 2032, expanding at a compound annual growth rate (CAGR) of 8.1% during the forecast period.

Antioxidants Market

The global antioxidants market was valued at USD 4,095.8 million in 2024 and is anticipated to reach USD 6,657.29 million by 2032, expanding at a CAGR of 6.26% during the forecast period.

U.S. Pharma R&D Outsourcing Market

US Pharma R&D Outsourcing Market size was valued at USD 30,916.90 Million in 2024 and is anticipated to reach USD 67,782.11 Million by 2032, at a CAGR of 10.31% during the forecast period.

Licensalternativ

The report comes as a view-only PDF document, optimized for individual clients. This version is recommended for personal digital use and does not allow printing. Use restricted to one purchaser only.
$4999

To meet the needs of modern corporate teams, our report comes in two formats: a printable PDF and a data-rich Excel sheet. This package is optimized for internal analysis. Unlimited users allowed within one corporate location (e.g., regional office).
$5999

The report will be delivered in printable PDF format along with the report’s data Excel sheet. This license offers 100 Free Analyst hours where the client can utilize Credence Research Inc. research team. Permitted for unlimited global use by all users within the purchasing corporation, such as all employees of a single company.
$7999

Report delivery within 24 to 48 hours

Snabbkontakt

Europe

+44 7453 598 606

North America

+1 6282 627 656

Email

[email protected]

Begär ett gratisprov

Smallform of Sample request

What people say?

User Review

Thank you for the data! The numbers are exactly what we asked for and what we need to build our business case.

Materialforskare
(privacy requested)

User Review

The report was an excellent overview of the Industrial Burners market. This report does a great job of breaking everything down into manageable chunks.

Imre Hof
Ledningsassistent, Bekaert

Betrodd av

cr-clients-logos

Request Sample